Literature DB >> 24549986

Betaine suppressed Aβ generation by altering amyloid precursor protein processing.

Xiu-Ping Liu1, Xiang Qian, Yue Xie, Yan Qi, Min-Feng Peng, Bi-Cui Zhan, Zheng-Qing Lou.   

Abstract

Betaine was an endogenous catabolite of choline, which could be isolated from vegetables and marine products. Betaine could promote the metabolism of homocysteine in healthy subjects and was used for hyperlipidemia, coronary atherosclerosis, and fatty liver in clinic. Recent findings shown that Betaine rescued neuronal damage due to homocysteine induced Alzheimer's disease (AD) like pathological cascade, including tau hyperphosphorylation and amyloid-β (Aβ) deposition. Aβ was derived from amyloid precursor protein (APP) processing, and was a triggering factor for AD pathological onset. Here, we demonstrated that Betaine reduced Aβ levels by altering APP processing in N2a cells stably expressing Swedish mutant of APP. Betaine increased α-secretase activity, but decreased β-secretase activity. Our data indicate that Betaine might play a protective role in Aβ production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549986     DOI: 10.1007/s10072-014-1630-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  20 in total

1.  Upregulation of astrocytes protein phosphatase-2A stimulates astrocytes migration via inhibiting p38 MAPK in tg2576 mice.

Authors:  Xiu-Ping Liu; Hong-Yun Zheng; Min Qu; Yao Zhang; Fu-Yuan Cao; Qun Wang; Dan Ke; Gong-Ping Liu; Jian-Zhi Wang
Journal:  Glia       Date:  2012-06-21       Impact factor: 7.452

Review 2.  Current therapeutic strategy in Alzheimer's disease.

Authors:  S Singh; A S Kushwah; R Singh; M Farswan; R Kaur
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-11       Impact factor: 3.507

3.  Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease.

Authors:  Matthew E Seward; Eric Swanson; Andrés Norambuena; Anja Reimann; J Nicholas Cochran; Rong Li; Erik D Roberson; George S Bloom
Journal:  J Cell Sci       Date:  2013-01-23       Impact factor: 5.285

4.  Hydroxysafflor yellow A ameliorates homocysteine-induced Alzheimer-like pathologic dysfunction and memory/synaptic disorder.

Authors:  Ya-Qin Lu; Yu Luo; Zhong-Fang He; Jun Chen; Bo-Ling Yan; Ying Wang; Qin Yu
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

5.  Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway.

Authors:  Kusum K Kharbanda; Mark E Mailliard; Cheryl R Baldwin; Harriet C Beckenhauer; Michael F Sorrell; Dean J Tuma
Journal:  J Hepatol       Date:  2006-10-26       Impact factor: 25.083

6.  Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study.

Authors:  B Hooshmand; A Solomon; I Kåreholt; J Leiviskä; M Rusanen; S Ahtiluoto; B Winblad; T Laatikainen; H Soininen; M Kivipelto
Journal:  Neurology       Date:  2010-10-19       Impact factor: 9.910

Review 7.  γ-Secretase as a target for Alzheimer's disease.

Authors:  Michael S Wolfe
Journal:  Adv Pharmacol       Date:  2012

8.  Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine.

Authors:  Gao-Shang Chai; Xia Jiang; Zhong-Fei Ni; Zhi-Wei Ma; Ao-Ji Xie; Xiang-Shu Cheng; Qun Wang; Jian-Zhi Wang; Gong-Ping Liu
Journal:  J Neurochem       Date:  2013-02       Impact factor: 5.372

9.  Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.

Authors:  Philip T T Ly; Yili Wu; Haiyan Zou; Ruitao Wang; Weihui Zhou; Ayae Kinoshita; Mingming Zhang; Yi Yang; Fang Cai; James Woodgett; Weihong Song
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

Review 10.  Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer's disease.

Authors:  Alexander A Boldyrev; Peter Johnson
Journal:  J Alzheimers Dis       Date:  2007-05       Impact factor: 4.472

View more
  5 in total

1.  Tongluo Xingnao effervescent tablet reverses memory deficit and reduces plaque load in APPswe/PS1dE9 mice.

Authors:  Wenjun Fu; Yuan Dai; Tao Ma; Jiangping Wei; Huan Chen; Shijun Xu
Journal:  Exp Ther Med       Date:  2018-02-26       Impact factor: 2.447

2.  Lavandula angustifolia Effects on Rat Models of Alzheimer's Disease Through the Investigation of Serum Metabolic Features Using NMR Metabolomics.

Authors:  Afsaneh Arefi Oskouie; Reyhaneh Farrokhi Yekta; Mostafa Rezaei Tavirani; Masoud Soheili Kashani; Fatemeh Goshadrou
Journal:  Avicenna J Med Biotechnol       Date:  2018 Apr-Jun

Review 3.  Current Screening Methodologies in Drug Discovery for Selected Human Diseases.

Authors:  Olga Maria Lage; María C Ramos; Rita Calisto; Eduarda Almeida; Vitor Vasconcelos; Francisca Vicente
Journal:  Mar Drugs       Date:  2018-08-14       Impact factor: 5.118

4.  Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer's Disease Mouse Model.

Authors:  Marta Zamarbide; Eva Martinez-Pinilla; Francisco Gil-Bea; Masashi Yanagisawa; Rafael Franco; Alberto Perez-Mediavilla
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

5.  Standardized Lycium chinense fruit extract enhances attention and cognitive function in healthy young people by a double-blind, randomized, placebo-controlled, crossover trial.

Authors:  Sun-Yong Chung; Moonkyu Kang; Seong-Bin Hong; Hyunsu Bae; Seung-Hun Cho
Journal:  J Res Med Sci       Date:  2019-12-23       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.